ICG A Boon to Stem Cell Tracking
More embryonic stem cell spin and propaganda. Increased or better claims off of something that does not work and give cancers is hardly an improvement. Adult stem cells work, with no ill side effects at much lower costs.
~ Uncle Russ
A study published in the current issue of Cell Transplantation (19:1) has found that using the FDA-approved contrast agent Indocyanine Green (ICG) to label human embryonic stem cell-derived cardiomyocytes (hESC-CMs) substantially improved efforts to optically track stem cells after transplanting them into heart tissues.